EVOK — Evoke Pharma Share News
0.000.00%
Last trade - 00:00- $18.86m
- $12.28m
- $10.25m
Brief: Evoke Pharma Receives Notice Of Allowance From USPTO For A Patent Related To Gimoti
Brief: Evoke Pharma and Eversana expand patient access to Gimoti® with new telehealth solution
Evoke Pharma Inc reports results for the quarter ended in June - Earnings Summary
Brief: Evoke Pharma Reports Second Quarter 2022 Financial Results
Evoke Pharma Inc expected to post a loss of 60 cents a share - Earnings Preview
Evoke Pharma on Canadian patent for nasal spray
Brief: Evoke Pharma Expands IP Portfolio With Addition Of Canadian Patent Covering Gimoti Method Of Use
Brief: Evoke Pharma Announces Approval Of Gimoti To Florida State Medicaid Program
Brief: Evoke Pharma Regains Compliance With Nasdaq Listing Requirements
Evoke Pharma Inc reports results for the quarter ended in March - Earnings Summary
Evoke Pharma Inc expected to post a loss of 4 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Polaris Inc, Invesco Ltd, Corning Inc
Brief: Evoke Pharma Granted FDA Market Exclusivity For Gimoti
Texas adds Evoke Pharma's nasal spray to Medicaid drug list; shares jump
Brief: Evoke Pharma Announces Approval Of Gimoti To Texas Medicaid Preferred Drug List
Brief: Evoke Pharma Reports Q4 And Full Year 2021 Financial Results
Brief: Evoke Pharma Reports Q4 Loss Per Share Of $0.05
Evoke Pharma Inc reports results for the quarter ended in December - Earnings Summary
Evoke Pharma Inc expected to post a loss of 8 cents a share - Earnings Preview